Covered recipient · General Payments record
PATRICK H DANG
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,271.76
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $217.06 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $70.73 | 4 |
| ABBVIE INC. | $41.27 | 2 |
| Abbott Laboratories | $37.41 | 2 |
| Acerta Pharma LLC | $20.84 | 1 |
| Lilly USA, LLC | $17.07 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.10 | 1 |
| TOLMAR, INC. | $14.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.39 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125159964 | CMS |
| Abbott Laboratories | $19.02 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125159966 | CMS |
| ABBVIE INC. | $21.44 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103598290 | CMS |
| ABBVIE INC. | $19.83 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103598292 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.84 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104528014 | CMS |
| Lilly USA, LLC | $17.07 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135263087 | CMS |
| Novo Nordisk Inc | $19.94 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096624150 | CMS |
| Novo Nordisk Inc | $15.97 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097009066 | CMS |
| Novo Nordisk Inc | $18.60 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096579069 | CMS |
| Novo Nordisk Inc | $16.22 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096907557 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.10 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153527445 | CMS |
| Tolmar, Inc. | $14.64 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138714196 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.